ENTRY       D12493            Mixture   Drug
NAME        Dextromethorphan hydrobromide and bupropion hydrochloride;
            Auvelity (TN)
PRODUCT     AUVELITY (Axsome Therapeutics)
COMPONENT   Dextromethorphan hydrobromide [DR:D00848], Bupropion hydrochloride [DR:D00817]
CLASS       Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      ATC code: N07XX59
            Product: D12493<US>
EFFICACY    Antidepressant
  DISEASE   Major depressive disorder [DS:H01646]
COMMENT     Dextromethorphan is primarily metabolized by CYP2D6.
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07X OTHER NERVOUS SYSTEM DRUGS
                N07XX Other nervous system drugs
                 N07XX59 Dextromethorphan, combinations
                  D12493  Dextromethorphan hydrobromide and bupropion hydrochloride &lt;US&gt;
            USP drug classification [BR:br08302]
             Antidepressants
              Antidepressants, Other
               Dextromethorphan Hydrobromide/ Bupropion Hydrochloride
                D12493  Dextromethorphan hydrobromide and bupropion hydrochloride
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D12493  Dextromethorphan hydrobromide and bupropion hydrochloride
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12493
///
